United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

mercury pharma group ltd - neostigmine metilsulfate; glycopyrronium bromide - solution for injection - 2.5mg/1ml ; 500microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - neostigmine metilsulfate; glycopyrronium bromide - solution for injection - 2.5mg/1ml ; 500microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - neostigmine metilsulfate; glycopyrronium bromide - solution for injection - 2.5mg/1ml ; 500microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - neostigmine metilsulfate; glycopyrronium bromide - solution for injection - 2.5mg/1ml ; 500microgram/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alliance healthcare (distribution) ltd - neostigmine metilsulfate; glycopyrronium bromide - solution for injection - 2.5mg/1ml ; 500microgram/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

max health limited - glycopyrronium bromide 0.5 mg/ml; neostigmine metilsulfate 2.5 mg/ml - solution for injection - active: glycopyrronium bromide 0.5 mg/ml neostigmine metilsulfate 2.5 mg/ml excipient: citric acid citric acid monohydrate dibasic sodium phosphate dodecahydrate sodium hydroxide water for injection - reversal of residual non-depolarising (competitive) neuromuscular block.

Ireland - English - HPRA (Health Products Regulatory Authority)

mercurypharm ltd - glycopyrronium bromide; neostigmine metilsulfate - solution for injection - 0.5mg /2.5 milligram(s)/millilitre - anticholinesterases; neostigmine, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

sintetica ireland limited - glycopyrronium bromide; neostigmine metilsulfate - solution for injection - 0.5 mg/ml + 2.5 milligram(s)/millilitre - glycopyrronium bromide

South Africa - English - South African Health Products Regulatory Authority (SAHPRA)

umsebe healthcare - injection - 0,5 mg & 2,5 mg - each 1,0 ml solution contains glycopyrronium bromide 0,5 mg neostigmine metilsulfate 2,5 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

sintetica gmbh - glycopyrronium bromide; neostigmine metilsulfate - solution for injection - glycopyrronium bromide